Gynaecological cancer incidence is increasing in number. There are many initiatives to reduce gynaecological cancers, such as cervical screening, the HPV vaccine and prophylactic surgery for BRCA1/2 Mutation carriers. However, with a growing and aging population, like many other cancer specialities, we will continue to see increasing numbers of cases.
In Ireland, the most common gynaecological cancer is uterine/endometrial carcinoma (550 cases/year). Followed by ovarian (400 cases/year, cervical (300 cases/year) and vulval/vaginal/other (170 cases/year).
Our service has seen an increase in activity and through our combines sites of MMUH & SVUH care for nearly 400 new cases each year alongside cases of recurrent cancer. The majority of cases require both surgical and medical treatments.
Clinical Activity
New cancer CASES UCD-GOG 2018 – 2020
Cancer Site |
2018 |
2019 |
2020 (January – August) |
Endometrial/Uterine |
139 |
133 |
72 |
Ovary |
102 |
148 |
103 |
Cervix |
46 |
50 |
27 |
Vulval/Vaginal |
19 |
29 |
17 |
TOTAL |
306 |
364 |
219 |
MDT PATHWAY & ACTIVITY
The treatment pathway of each patient is personalised by our multidisciplinary team meeting (MDT), which is held weekly in the Mater Hospital and fortnightly in St Vincent’s Hospital.
Referral information to both MDTs can be found at individual websites
(opens in a new window)St. Vincent's University Hospital - Gynaecology
(opens in a new window)Mater Misericordiae University Hospital - Gynaecological Oncology
MDT REFERRALS UCD-GOG 2018 – 2020
|
2018 |
2019 |
2020 January - Sept |
New MDT Referrals |
716 |
757 |
631 |
Total MDT Discussions |
989 |
1215 |
1131 |
UCD School of Medicine
UCD Health Sciences Centre, University College Dublin, Belfield, Dublin 4, Ireland. T: +353 1 716 6603 | E: school.medicine@ucd.ieAdditional Text Here is Optional